Syros Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • Syros Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 39.3M shares, a 40.5% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 28.3M shares, a 124% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.6M shares, a 102% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 6.25M shares, a 35.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 28.3M +15.7M +124% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 12.6M +6.38M +102% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 6.25M +1.65M +35.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 4.61M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.